Leaflet SPIOLTO RESPIMAT 2.5mcg / 2.5mcg inhalation solution


Indicated for: asthma; chronic obstructive pulmonary disease

Route of administration: inhalation

Substance: tiotropium + olodaterol (antimuscarinic bronchodilator + beta-2 adrenergic agonist)

ATC: R03AL06 (Respiratory system | Adrenergics, inhalants | Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids)

Precautions:
Glaucoma warning
Glaucoma warning

Use caution if you have glaucoma or increased eye pressure.

Anticholinergic effects
Anticholinergic effects

May cause dry mouth, constipation, urinary retention, or blurred vision.

Hyperglycemia
Hyperglycemia

This medicine may increase blood sugar.

Breastfeeding warning
Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning
Pregnancy warning

Use during pregnancy only on medical advice.

Elderly warning
Elderly warning

Older people may have an increased risk of side effects.

Cardiac risk / QT prolongation / arrhythmias
Cardiac risk / QT prolongation / arrhythmias

This medicine may increase the risk of heart rhythm disturbances.

The combination of tiotropium and olodaterol is used for the treatment of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. Tiotropium is an anticholinergic bronchodilator, and olodaterol is a long-acting beta-2 adrenergic agonist. Together, they relax the airway muscles and improve lung function.

The medication is administered via inhaler, usually once daily, as directed by a doctor. It is used for long-term control of symptoms and not for quick relief of breathing crises.

Patients should strictly follow the instructions for using the inhaler and inform their doctor of any unusual symptoms. It is important not to exceed the recommended dose.

Side effects may include dry mouth, cough, dizziness, and, in rare cases, severe allergic reactions or breathing difficulties. Patients should be informed of these risks before starting treatment.

SPIOLTO RESPIMAT 2.5mcg/2.5mcg inhalation solution BOEHRINGER, tiotropium+olodaterol

General data about SPIOLTO RESPIMAT 2.5mcg / 2.5mcg

  • Substance: tiotropium + olodaterol
  • Date of last drug list: 01-06-2026
  • Commercial code: W61818007
  • Concentration: 2.5mcg / 2.5mcg
  • Pharmaceutical form: inhalation solution
  • Quantity: 1
  • Product type: original
  • Price: 211.91 RON
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG - GERMANIA
  • Holder: BOEHRINGER INGELHEIM INTERNATIONAL GMBH - GERMANIA
  • Number: 13224/2020/01
  • Shelf life: 3 years; after the first opening a cartusului - 3 months; dupa prima utilizare a inhalatorului - 1 year

Compensation lists for SPIOLTO RESPIMAT 2.5mcg / 2.5mcg Boehringer

B - Sublist B with 50% discount from the reference price

Price

Copayment

Patient

211.91 RON

105.96 RON

105.96 RON